- Home
- MVIS vs TOI Comparison
MVIS vs TOI Comparison
Compare MVIS & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVIS
- TOI
- Stock Information
- Founded
- MVIS 1993
- TOI 2007
- Country
- MVIS United States
- TOI United States
- Employees
- MVIS N/A
- TOI N/A
- Industry
- MVIS Industrial Machinery/Components
- TOI Medical/Nursing Services
- Sector
- MVIS Technology
- TOI Health Care
- Exchange
- MVIS Nasdaq
- TOI Nasdaq
- Market Cap
- MVIS 287.6M
- TOI 266.8M
- IPO Year
- MVIS 1996
- TOI N/A
- Fundamental
- Price
- MVIS $1.15
- TOI $2.39
- Analyst Decision
- MVIS Buy
- TOI
- Analyst Count
- MVIS 4
- TOI 0
- Target Price
- MVIS $2.50
- TOI N/A
- AVG Volume (30 Days)
- MVIS 7.1M
- TOI 1.9M
- Earning Date
- MVIS 08-06-2025
- TOI 08-12-2025
- Dividend Yield
- MVIS N/A
- TOI N/A
- EPS Growth
- MVIS N/A
- TOI N/A
- EPS
- MVIS N/A
- TOI N/A
- Revenue
- MVIS $4,329,000.00
- TOI $403,152,000.00
- Revenue This Year
- MVIS $508.18
- TOI $23.95
- Revenue Next Year
- MVIS $86.32
- TOI N/A
- P/E Ratio
- MVIS N/A
- TOI N/A
- Revenue Growth
- MVIS N/A
- TOI 17.64
- 52 Week Low
- MVIS $0.80
- TOI $0.13
- 52 Week High
- MVIS $1.95
- TOI $3.50
- Technical
- Relative Strength Index (RSI)
- MVIS 54.63
- TOI 38.68
- Support Level
- MVIS $1.07
- TOI $2.28
- Resistance Level
- MVIS $1.38
- TOI $2.87
- Average True Range (ATR)
- MVIS 0.09
- TOI 0.24
- MACD
- MVIS 0.01
- TOI -0.10
- Stochastic Oscillator
- MVIS 51.94
- TOI 1.24
About MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.